News & Events

News

  • Post date

  • Tags

  • By author

Advanced search
December 11, 2018 Cambrex Expands Analytical Capabilities at its High Point, NC Site
November 20, 2018 Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network
November 8, 2018 Cambrex Reports Third Quarter 2018 Financial Results
November 5, 2018 Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018
October 8, 2018 Cambrex Invests c.$3 Million to Upgrade Generic API Manufacturing Facilities at Milan, Italy Site
September 25, 2018 Cambrex to Expand and Invest at High Point, NC Site to Create New Center of Excellence for Process Development and Clinical Supply
September 12, 2018 Cambrex Completes Acquisition of Halo Pharma
August 29, 2018 Cambrex to present at upcoming investor conferences in September
August 2, 2018 Cambrex reports second quarter 2018 financial results
July 27, 2018 Cambrex to Announce Second Quarter 2018 Financial Results on August 2, 2018
July 23, 2018 Cambrex to Acquire Halo Pharma, Adding Drug Development and Finished Dosage Capabilities to Global API Manufacturing Network
June 12, 2018 Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site

Cambrex experts

Our people are the experts you’ll enjoy working with.

Quality

We go beyond delivering the essential quality and reliability required in API development and manufacturing.

Working with us

Our dedicated team are here for you from development to commercial supply.

Regulatory
excellence

We are committed to compliance and have a long history of regulatory excellence.